The evolving concept of cancer and metastasis stem cells

Journal of Cell Biology

Volumn 198, Issue 3, 2012, Pages 281-293

  Baccelli, Irène ^a,b   Trumpp, Andreas ^a,b  

^a Heidelberg Institute for Stem Cell Technology and Experimental Medicine HI STEM   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER GENETICS; CANCER RELAPSE; CANCER STEM CELL; CARCINOGENESIS; CELL CLONING; HUMAN; METASTASIS; NONHUMAN; PRIORITY JOURNAL; TUMOR MICROENVIRONMENT; TUMOR VOLUME;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MODELS, GENETIC; NEOPLASM METASTASIS; NEOPLASMS; NEOPLASTIC STEM CELLS; RECURRENCE; SIGNAL TRANSDUCTION; TUMOR MARKERS, BIOLOGICAL;

EID: 84866447416     PISSN: 00219525     EISSN: 15408140     Source Type: Journal    
DOI: 10.1083/jcb.201202014     Document Type: Article

References (160)

1. Aguirre-Ghiso, J.A. 2007. Models, mechanisms and clinical evidence for cancer dormancy. Nat. Rev. Cancer. 7: 834-846. http://dx.doi.org/10.1038/nrc2256
2. Akala, O.O., I.K. Park, D. Qian, M. Pihalja, M.W. Becker, and M.F. Clarke. 2008. Long-term haematopoietic reconstitution by Trp53-/-p16Ink4a-/-p19Arf-/- multipotent progenitors. Nature. 453: 228-232. http://dx.doi.org/10.1038/nature06869.
3. Al-Hajj, M., M.S. Wicha, A. Benito-Hernandez, S.J. Morrison, and M.F. Clarke. 2003. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. USA. 100: 3983-3988. http://dx.doi.org/10.1073/pnas.0530291100
4. American Cancer Society. 2011. Cancer Facts & Figures 2011. American Cancer Society, Atlanta. 58 pp.
5. Anderson, K., C. Lutz, F.W. van Delft, C.M. Bateman, Y. Guo, S.M. Colman, H. Kempski, A.V. Moorman, I. Titley, J. Swansbury, et al. 2011. Genetic variegation of clonal architecture and propagating cells in leukaemia. Nature. 469: 356-361. http://dx.doi.org/10.1038/nature09650
6. Balic, M., H. Lin, L. Young, D. Hawes, A. Giuliano, G. McNamara, R.H. Datar, and R.J. Cote. 2006. Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype. Clin. Cancer Res. 12: 5615-5621. http://dx.doi.org/10.1158/1078-0432.CCR-06-0169
7. Bao, S., Q. Wu, R.E. McLendon, Y. Hao, Q. Shi, A.B. Hjelmeland, M.W. Dewhirst, D.D. Bigner, and J.N. Rich. 2006. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature. 444: 756-760. http://dx.doi.org/10.1038/nature05236
8. Barnes, D.J., and J.V. Melo. 2006. Primitive, quiescent and difficult to kill: the role of non-proliferating stem cells in chronic myeloid leukemia. Cell Cycle. 5: 2862-2866. http://dx.doi.org/10.4161/cc.5.24.3573
9. Bissell, M.J., and W.C. Hines. 2011. Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression. Nat. Med. 17: 320-329. http://dx.doi.org/10.1038/nm.2328
10. Blagosklonny, M.V. 2006. Target for cancer therapy: proliferating cells or stem cells. Leukemia. 20: 385-391. http://dx.doi.org/10.1038/sj.leu.2404075
11. Boiko, A.D., O.V. Razorenova, M. van de Rijn, S.M. Swetter, D.L. Johnson, D.P. Ly, P.D. Butler, G.P. Yang, B. Joshua, M.J. Kaplan, et al. 2010. Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271. Nature. 466: 133-137. http://dx.doi.org/10.1038/nature09161
12. Bonnet, D., and J.E. Dick. 1997. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 3: 730-737. http://dx.doi.org/10.1038/nm0797-730
13. Bos, P.D., X.H. Zhang, C. Nadal, W. Shu, R.R. Gomis, D.X. Nguyen, A.J. Minn, M.J. van de Vijver, W.L. Gerald, J.A. Foekens, and J. Massagué. 2009. Genes that mediate breast cancer metastasis to the brain. Nature. 459: 1005-1009. http://dx.doi.org/10.1038/nature08021
14. Cabarcas, S.M., L.A. Mathews, and W.L. Farrar. 2011. The cancer stem cell niche-there goes the neighborhood? Int. J. Cancer. 129: 2315-2327. http://dx.doi.org/10.1002/ijc.26312
15. Calabrese, C., H. Poppleton, M. Kocak, T.L. Hogg, C. Fuller, B. Hamner, E.Y. Oh, M.W. Gaber, D. Finklestein, M. Allen, et al. 2007. A perivascular niche for brain tumor stem cells. Cancer Cell. 11: 69-82. http://dx.doi.org/10.1016/j.ccr.2006.11.020
16. Campbell, P.J., S. Yachida, L.J. Mudie, P.J. Stephens, E.D. Pleasance, L.A. Stebbings, L.A. Morsberger, C. Latimer, S. McLaren, M.L. Lin, et al. 2010. The patterns and dynamics of genomic instability in metastatic pancreatic cancer. Nature. 467: 1109-1113. http://dx.doi.org/10.1038/nature09460
17. Chan, K.S., I. Espinosa, M. Chao, D. Wong, L. Ailles, M. Diehn, H. Gill, J. Presti Jr., H.Y. Chang, M. van de Rijn, et al. 2009. Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells. Proc. Natl. Acad. Sci. USA. 106: 14016-14021. http://dx.doi.org/10.1073/pnas.0906549106
18. Cho, R.W., X. Wang, M. Diehn, K. Shedden, G.Y. Chen, G. Sherlock, A. Gurney, J. Lewicki, and M.F. Clarke. 2008. Isolation and molecular characterization of cancer stem cells in MMTV-Wnt-1 murine breast tumors. Stem Cells. 26: 364-371. http://dx.doi.org/10.1634/stemcells.2007-0440
19. Civenni, G., A. Walter, N. Kobert, D. Mihic-Probst, M. Zipser, B. Belloni, B. Seifert, H. Moch, R. Dummer, M. van den Broek, and L. Sommer. 2011. Human CD271-positive melanoma stem cells associated with metastasis establish tumor heterogeneity and long-term growth. Cancer Res. 71: 3098-3109. http://dx.doi.org/10.1158/0008-5472.CAN-10-3997
20. Clevers, H. 2011. The cancer stem cell: premises, promises and challenges. Nat. Med. 17: 313-319. http://dx.doi.org/10.1038/nm.2304
21. Colmone, A., M. Amorim, A.L. Pontier, S. Wang, E. Jablonski, and D.A. Sipkins. 2008. Leukemic cells create bone marrow niches that disrupt the behavior of normal hematopoietic progenitor cells. Science. 322: 1861-1865. http://dx.doi.org/10.1126/science.1164390
22. Cordenonsi, M., F. Zanconato, L. Azzolin, M. Forcato, A. Rosato, C. Frasson, M. Inui, M. Montagner, A.R. Parenti, A. Poletti, et al. 2011. The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells. Cell. 147: 759-772. http://dx.doi.org/10.1016/j.cell.2011.09.048
23. Curtis, C., S.P. Shah, S.F. Chin, G. Turashvili, O.M. Rueda, M.J. Dunning, D. Speed, A.G. Lynch, S. Samarajiwa, Y. Yuan, et al. 2012. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature. 486:346-352.
24. Dalerba, P., S.J. Dylla, I.K. Park, R. Liu, X. Wang, R.W. Cho, T. Hoey, A. Gurney, E.H. Huang, D.M. Simeone, et al. 2007. Phenotypic characterization of human colorectal cancer stem cells. Proc. Natl. Acad. Sci. USA. 104: 10158-10163. http://dx.doi.org/10.1073/pnas.0703478104
25. Dean, M., T. Fojo, and S. Bates. 2005. Tumour stem cells and drug resistance. Nat. Rev. Cancer. 5: 275-284. http://dx.doi.org/10.1038/nrc1590
26. de Thé, H., and Z. Chen. 2010. Acute promyelocytic leukaemia: novel insights into the mechanisms of cure. Nat. Rev. Cancer. 10: 775-783. http://dx.doi.org/10.1038/nrc2943
27. Deonarain, M.P., C.A. Kousparou, and A.A. Epenetos. 2009. Antibodies targeting cancer stem cells: a new paradigm in immunotherapy? MAbs. 1:12-25.
28. Deshpande, A.J., M. Cusan, V.P. Rawat, H. Reuter, A. Krause, C. Pott, L. Quintanilla-Martinez, P. Kakadia, F. Kuchenbauer, F. Ahmed, et al. 2006. Acute myeloid leukemia is propagated by a leukemic stem cell with lymphoid characteristics in a mouse model of CALM/AF10-positive leukemia. Cancer Cell. 10: 363-374. http://dx.doi.org/10.1016/j.ccr.2006.08.023
29. Dick, J.E. 2008. Stem cell concepts renew cancer research. Blood. 112: 4793-4807. http://dx.doi.org/10.1182/blood-2008-08-077941
30. Diehn, M., R.W. Cho, N.A. Lobo, T. Kalisky, M.J. Dorie, A.N. Kulp, D. Qian, J.S. Lam, L.E. Ailles, M. Wong, et al. 2009. Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature. 458: 780-783. http://dx.doi.org/10.1038/nature07733
31. Dieter, S.M., C.R. Ball, C.M. Hoffmann, A. Nowrouzi, F. Herbst, O. Zavidij, U. Abel, A. Arens, W. Weichert, K. Brand, et al. 2011. Distinct types of tumor-initiating cells form human colon cancer tumors and metastases. Cell Stem Cell. 9: 357-365. http://dx.doi.org/10.1016/j.stem.2011.08.010
32. Douville, J., R. Beaulieu, and D. Balicki. 2009. ALDH1 as a functional marker of cancer stem and progenitor cells. Stem Cells Dev. 18: 17-25. http://dx.doi.org/10.1089/scd.2008.0055
33. Druker, B.J., F. Guilhot, S.G. O'Brien, I. Gathmann, H. Kantarjian, N. Gattermann, M.W. Deininger, R.T. Silver, J.M. Goldman, R.M. Stone, et al. 2006. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. N. Engl. J. Med. 355: 2408-2417. http://dx.doi.org/10.1056/NEJMoa062867
34. Ehninger, A., and A. Trumpp. 2011. The bone marrow stem cell niche grows up: mesenchymal stem cells and macrophages move in. J. Exp. Med. 208: 421-428. http://dx.doi.org/10.1084/jem.20110132
35. Eppert, K., K. Takenaka, E.R. Lechman, L. Waldron, B. Nilsson, P. van Galen, K.H. Metzeler, A. Poeppl, V. Ling, J. Beyene, et al. 2011. Stem cell gene expression programs influence clinical outcome in human leukemia. Nat. Med. 17: 1086-1093. http://dx.doi.org/10.1038/nm.2415
36. Eramo, A., F. Lotti, G. Sette, E. Pilozzi, M. Biffoni, A. Di Virgilio, C. Conticello, L. Ruco, C. Peschle, and R. De Maria. 2008. Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ. 15: 504-514. http://dx.doi.org/10.1038/sj.cdd.4402283
37. Erez, N., and L.M. Coussens. 2011. Leukocytes as paracrine regulators of metastasis and determinants of organ-specific colonization. Int. J. Cancer. 128: 2536-2544. http://dx.doi.org/10.1002/ijc.26032
38. Essers, M.A., and A. Trumpp. 2010. Targeting leukemic stem cells by breaking their dormancy. Mol. Oncol. 4: 443-450. http://dx.doi.org/10.1016/j.molonc.2010.06.001
39. Essers, M.A., S. Offner, W.E. Blanco-Bose, Z. Waibler, U. Kalinke, M.A. Duchosal, and A. Trumpp. 2009. IFNalpha activates dormant haematopoietic stem cells in vivo. Nature. 458: 904-908. http://dx.doi.org/10.1038/nature07815
40. Eyler, C.E., Q. Wu, K. Yan, J.M. MacSwords, D. Chandler-Militello, K.L. Misuraca, J.D. Lathia, M.T. Forrester, J. Lee, J.S. Stamler, et al. 2011. Glioma stem cell proliferation and tumor growth are promoted by nitric oxide synthase-2. Cell. 146: 53-66. http://dx.doi.org/10.1016/j.cell.2011.06.006
41. Fan, X., W. Matsui, L. Khaki, D. Stearns, J. Chun, Y.M. Li, and C.G. Eberhart. 2006. Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors. Cancer Res. 66: 7445-7452. http://dx.doi.org/10.1158/0008-5472.CAN-06-0858
42. Francipane, M.G., M.P. Alea, Y. Lombardo, M. Todaro, J.P. Medema, and G. Stassi. 2008. Crucial role of interleukin-4 in the survival of colon cancer stem cells. Cancer Res. 68: 4022-4025. http://dx.doi.org/10.1158/0008-5472.CAN-07-6874
43. Fuchs, E. 2009. The tortoise and the hair: slow-cycling cells in the stem cell race. Cell. 137: 811-819. http://dx.doi.org/10.1016/j.cell.2009.05.002
44. Fuchs, E., and J.A. Nowak. 2008. Building epithelial tissues from skin stem cells. Cold Spring Harb. Symp. Quant. Biol. 73: 333-350. http://dx.doi.org/10.1101/sqb.2008.73.032
45. Gerlinger, M., A.J. Rowan, S. Horswell, J. Larkin, D. Endesfelder, E. Gronroos, P. Martinez, N. Matthews, A. Stewart, P. Tarpey, et al. 2012. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N. Engl. J. Med. 366: 883-892. http://dx.doi.org/10.1056/NEJMoa1113205
46. Gibbs, K.D. Jr., A. Jager, O. Crespo, Y. Goltsev, A. Trejo, C.E. Richard, and G.P. Nolan. 2012. Decoupling of tumor-initiating activity from stable immunophenotype in HoxA9-Meis1-driven AML. Cell Stem Cell. 10: 210-217. http://dx.doi.org/10.1016/j.stem.2012.01.004
47. Ginestier, C., M.H. Hur, E. Charafe-Jauffret, F. Monville, J. Dutcher, M. Brown, J. Jacquemier, P. Viens, C.G. Kleer, S. Liu, et al. 2007. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell. 1: 555-567. http://dx.doi.org/10.1016/j.stem.2007.08.014
48. Goh, A.M., C.R. Coffill, and D.P. Lane. 2011. The role of mutant p53 in human cancer. J. Pathol. 223: 116-126. http://dx.doi.org/10.1002/path.2784
49. Goldman, J.M. 2010. Chronic myeloid leukemia: a historical perspective. Semin. Hematol. 47: 302-311. http://dx.doi.org/10.1053/j.seminhematol.2010.07.001
50. Goldman, J.M., A.R. Green, T. Holyoake, C. Jamieson, R. Mesa, T. Mughal, F. Pellicano, D. Perrotti, R. Skoda, and A.M. Vannucchi. 2009. Chronic myeloproliferative diseases with and without the Ph chromosome: some unresolved issues. Leukemia. 23: 1708-1715. http://dx.doi.org/10.1038/leu.2009.142
51. Grivennikov, S., E. Karin, J. Terzic, D. Mucida, G.Y. Yu, S. Vallabhapurapu, J. Scheller, S. Rose-John, H. Cheroutre, L. Eckmann, and M. Karin. 2009. IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell. 15: 103-113. http://dx.doi.org/10.1016/j.ccr.2009.01.001
52. Gupta, G.P., A.J. Minn, Y. Kang, P.M. Siegel, I. Serganova, C. Cordón-Cardo, A.B. Olshen, W.L. Gerald, and J. Massagué. 2005. Identifying site-specific metastasis genes and functions. Cold Spring Harb. Symp. Quant.Biol. 70: 149-158. http://dx.doi.org/10.1101/sqb.2005.70.018
53. Gupta, P.B., T.T. Onder, G. Jiang, K. Tao, C. Kuperwasser, R.A. Weinberg, and E.S. Lander. 2009. Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell. 138: 645-659. http://dx.doi.org/10.1016/j.cell.2009.06.034
54. Gupta, P.B., C.M. Fillmore, G. Jiang, S.D. Shapira, K. Tao, C. Kuperwasser, and E.S. Lander. 2011. Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells. Cell. 146: 633-644. http://dx.doi.org/10.1016/j.cell.2011.07.026
55. Guzman, M.L., R.M. Rossi, L. Karnischky, X. Li, D.R. Peterson, D.S. Howard, and C.T. Jordan. 2005. The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells. Blood. 105: 4163-4169. http://dx.doi.org/10.1182/blood-2004-10-4135
56. Hanahan, D., and L.M. Coussens. 2012. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell. 21: 309-322. http://dx.doi.org/10.1016/j.ccr.2012.02.022
57. Heider, K.H., H. Kuthan, G. Stehle, and G. Munzert. 2004. CD44v6: a target for antibody-based cancer therapy. Cancer Immunol. Immunother. 53: 567-579. http://dx.doi.org/10.1007/s00262-003-0494-4
58. Hermann, D.M., E. Kilic, A. Spudich, S.D. Krämer, H. Wunderli-Allenspach, and C.L. Bassetti. 2006. Role of drug efflux carriers in the healthy and diseased brain. Ann. Neurol. 60: 489-498. http://dx.doi.org/10.1002/ana.21012
59. Hermann, P.C., S.L. Huber, T. Herrler, A. Aicher, J.W. Ellwart, M. Guba, C.J. Bruns, and C. Heeschen. 2007. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell. 1: 313-323. http://dx.doi.org/10.1016/j.stem.2007.06.002
60. Herschkowitz, J.I., K. Simin, V.J. Weigman, I. Mikaelian, J. Usary, Z. Hu, K.E. Rasmussen, L.P. Jones, S. Assefnia, S. Chandrasekharan, et al. 2007. Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. Genome Biol. 8:R76. http://dx.doi.org/10.1186/gb-2007-8-5-r76
61. Hess, J., P. Ruf, and H. Lindhofer. 2012. Cancer therapy with trifunctional antibodies: linking innate and adaptive immunity. Future Oncol. 8: 73-85. http://dx.doi.org/10.2217/fon.11.138
62. Ho, M.M., A.V. Ng, S. Lam, and J.Y. Hung. 2007. Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Res. 67: 4827-4833. http://dx.doi.org/10.1158/0008-5472.CAN-06-3557
63. Hope, K.J., L. Jin, and J.E. Dick. 2004. Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity. Nat. Immunol. 5: 738-743. http://dx.doi.org/10.1038/ni1080
64. Huang, E.H., M.J. Hynes, T. Zhang, C. Ginestier, G. Dontu, H. Appelman, J.Z. Fields, M.S. Wicha, and B.M. Boman. 2009. Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Res. 69: 3382-3389. http://dx.doi.org/10.1158/0008-5472.CAN-08-4418
65. Illmensee, K., and B. Mintz. 1976. Totipotency and normal differentiation of single teratocarcinoma cells cloned by injection into blastocysts. Proc. Natl. Acad. Sci. USA. 73: 549-553. http://dx.doi.org/10.1073/pnas.73.2.549
66. Ishikawa, F., S. Yoshida, Y. Saito, A. Hijikata, H. Kitamura, S. Tanaka, R. Nakamura, T. Tanaka, H. Tomiyama, N. Saito, et al. 2007. Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region. Nat. Biotechnol. 25: 1315-1321. http://dx.doi.org/10.1038/nbt1350
67. Ishizawa, K., Z.A. Rasheed, R. Karisch, Q. Wang, J. Kowalski, E. Susky, K. Pereira, C. Karamboulas, N. Moghal, N.V. Rajeshkumar, et al. 2010. Tumor-initiating cells are rare in many human tumors. Cell Stem Cell. 7: 279-282. http://dx.doi.org/10.1016/j.stem.2010.08.009
68. Ito, K., R. Bernardi, A. Morotti, S. Matsuoka, G. Saglio, Y. Ikeda, J. Rosenblatt, D.E. Avigan, J. Teruya-Feldstein, and P.P. Pandolfi. 2008. PML targeting eradicates quiescent leukaemia-initiating cells. Nature. 453: 1072-1078. http://dx.doi.org/10.1038/nature07016
69. Jamieson, C.H., L.E. Ailles, S.J. Dylla, M. Muijtjens, C. Jones, J.L. Zehnder, J. Gotlib, K. Li, M.G. Manz, A. Keating, et al. 2004. Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N. Engl. J. Med. 351: 657-667. http://dx.doi.org/10.1056/NEJMoa040258
70. Jemal, A., F. Bray, M.M. Center, J. Ferlay, E. Ward, and D. Forman. 2011. Global cancer statistics. CA Cancer J. Clin. 61: 69-90. http://dx.doi.org/10.3322/caac.20107
71. Jin, L., K.J. Hope, Q. Zhai, F. Smadja-Joffe, and J.E. Dick. 2006. Targeting of CD44 eradicates human acute myeloid leukemic stem cells. Nat. Med. 12: 1167-1174. http://dx.doi.org/10.1038/nm1483
72. Jin, L., E.M. Lee, H.S. Ramshaw, S.J. Busfield, A.G. Peoppl, L. Wilkinson, M.A. Guthridge, D. Thomas, E.F. Barry, A. Boyd, et al. 2009. Monoclonal antibody-mediated targeting of CD123, IL-3 receptor alpha chain, eliminates human acute myeloid leukemic stem cells. Cell Stem Cell. 5: 31-42. http://dx.doi.org/10.1016/j.stem.2009.04.018
73. Joseph, N.M., J.T. Mosher, J. Buchstaller, P. Snider, P.E. McKeever, M. Lim, S.J. Conway, L.F. Parada, Y. Zhu, and S.J. Morrison. 2008. The loss of Nf1 transiently promotes self-renewal but not tumorigenesis by neural crest stem cells. Cancer Cell. 13: 129-140. http://dx.doi.org/10.1016/j.ccr.2008.01.003
74. Kang, Y., P.M. Siegel, W. Shu, M. Drobnjak, S.M. Kakonen, C. Cordón-Cardo, T.A. Guise, and J. Massagué. 2003. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell. 3: 537-549. http://dx.doi.org/10.1016/S1535-6108(03)00132-6
75. Keck, T., and T. Brabletz. 2011. Under stress: p53 controls EMT and stemness in pancreatic epithelial cells. Cell Cycle. 10:1715. http://dx.doi.org/10.4161/cc.10.11.15645
76. Kelly, P.N., A. Dakic, J.M. Adams, S.L. Nutt, and A. Strasser. 2007. Tumor growth need not be driven by rare cancer stem cells. Science. 317:337. http://dx.doi.org/10.1126/science.1142596
77. Klein, C.A. 2009. Parallel progression of primary tumours and metastases. Nat. Rev. Cancer. 9: 302-312. http://dx.doi.org/10.1038/nrc2627
78. Kong, Y., S. Yoshida, Y. Saito, T. Doi, Y. Nagatoshi, M. Fukata, N. Saito, S.M. Yang, C. Iwamoto, J. Okamura, et al. 2008. CD34+CD38+CD19+ as well as CD34+CD38-CD19+ cells are leukemia-initiating cells with self-renewal capacity in human B-precursor ALL. Leukemia. 22:1207-1213. http://dx.doi.org/10.1038/leu.2008.83
79. Krause, D.S., K. Lazarides, U.H. von Andrian, and R.A. Van Etten. 2006. Requirement for CD44 in homing and engraftment of BCR-ABL-expressing leukemic stem cells. Nat. Med. 12:1175-1180. http://dx.doi.org/10.1038/nm1489
80. Krivtsov, A.V., D. Twomey, Z. Feng, M.C. Stubbs, Y. Wang, J. Faber, J.E. Levine, J. Wang, W.C. Hahn, D.G. Gilliland, et al. 2006. Transformation from committed progenitor to leukaemia stem cell initiated by MLLAF9. Nature. 442:818-822. http://dx.doi.org/10.1038/nature04980
81. Lapidot, T., C. Sirard, J. Vormoor, B. Murdoch, T. Hoang, J. Caceres-Cortes, M. Minden, B. Paterson, M.A. Caligiuri, and J.E. Dick. 1994. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature. 367:645-648. http://dx.doi.org/10.1038/367645a0
82. Li, C., D.G. Heidt, P. Dalerba, C.F. Burant, L. Zhang, V. Adsay, M. Wicha, M.F. Clarke, and D.M. Simeone. 2007. Identification of pancreatic cancer stem cells. Cancer Res. 67:1030-1037. http://dx.doi.org/10.1158/0008-5472.CAN-06-2030
83. Li, X., M.T. Lewis, J. Huang, C. Gutierrez, C.K. Osborne, M.F. Wu, S.G. Hilsenbeck, A. Pavlick, X. Zhang, G.C. Chamness, et al. 2008. Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. J. Natl. Cancer Inst. 100:672-679. http://dx.doi.org/10.1093/jnci/djn123
84. Li, H., M. Collado, A. Villasante, K. Strati, S. Ortega, M. Cañamero, M.A. Blasco, and M. Serrano. 2009a. The Ink4/Arf locus is a barrier for iPS cell reprogramming. Nature. 460:1136-1139. http://dx.doi.org/10.1038/nature08290
85. Li, Z., S. Bao, Q. Wu, H. Wang, C. Eyler, S. Sathornsumetee, Q. Shi, Y. Cao, J. Lathia, R.E. McLendon, et al. 2009b. Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. Cancer Cell. 15:501-513. http://dx.doi.org/10.1016/j.ccr.2009.03.018
86. Liu, H., M.R. Patel, J.A. Prescher, A. Patsialou, D. Qian, J. Lin, S. Wen, Y.F. Chang, M.H. Bachmann, Y. Shimono, et al. 2010. Cancer stem cells from human breast tumors are involved in spontaneous metastases in orthotopic mouse models. Proc. Natl. Acad. Sci. USA. 107:18115-18120. http://dx.doi.org/10.1073/pnas.1006732107
87. Lou, H., and M. Dean. 2007. Targeted therapy for cancer stem cells: the patched pathway and ABC transporters. Oncogene. 26:1357-1360. http://dx.doi.org/10.1038/sj.onc.1210200
88. Lu, D., M.Y. Choi, J. Yu, J.E. Castro, T.J. Kipps, and D.A. Carson. 2011. Salinomycin inhibits Wnt signaling and selectively induces apoptosis in chronic lymphocytic leukemia cells. Proc. Natl. Acad. Sci. USA. 108:13253-13257. http://dx.doi.org/10.1073/pnas.1110431108
89. Magee, J.A., E. Piskounova, and S.J. Morrison. 2012. Cancer stem cells: impact, heterogeneity, and uncertainty. Cancer Cell. 21:283-296. http://dx.doi.org/10.1016/j.ccr.2012.03.003
90. Malanchi, I., H. Peinado, D. Kassen, T. Hussenet, D. Metzger, P. Chambon, M. Huber, D. Hohl, A. Cano, W. Birchmeier, and J. Huelsken. 2008. Cutaneous cancer stem cell maintenance is dependent on betacatenin signalling. Nature. 452:650-653. http://dx.doi.org/10.1038/nature06835
91. Malanchi, I., A. Santamaria-Martínez, E. Susanto, H. Peng, H.A. Lehr, J.F. Delaloye, and J. Huelsken. 2012. Interactions between cancer stem cells and their niche govern metastatic colonization. Nature. 481:85-89. http://dx.doi.org/10.1038/nature10694
92. Mani, S.A., W. Guo, M.J. Liao, E.N. Eaton, A. Ayyanan, A.Y. Zhou, M. Brooks, F. Reinhard, C.C. Zhang, M. Shipitsin, et al. 2008. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 133:704-715. http://dx.doi.org/10.1016/j.cell.2008.03.027
93. Minn, A.J., G.P. Gupta, P.M. Siegel, P.D. Bos, W. Shu, D.D. Giri, A. Viale, A.B. Olshen, W.L. Gerald, and J. Massagué. 2005. Genes that mediate breast cancer metastasis to lung. Nature. 436:518-524. http://dx.doi.org/10.1038/nature03799
94. Miyamoto, T., I.L. Weissman, and K. Akashi. 2000. AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation. Proc. Natl. Acad. Sci. USA. 97: 7521-7526. http://dx.doi.org/10.1073/pnas.97.13.7521
95. Moshaver, B., A. van Rhenen, A. Kelder, M. van der Pol, M. Terwijn, C. Bachas, A.H. Westra, G.J. Ossenkoppele, S. Zweegman, and G.J. Schuurhuis. 2008. Identification of a small subpopulation of candidate leukemia-initiating cells in the side population of patients with acute myeloid leukemia. Stem Cells. 26: 3059-3067. http://dx.doi.org/10.1634/stemcells.2007-0861
96. Murphy, M.J., A. Wilson, and A. Trumpp. 2005. More than just proliferation: Myc function in stem cells. Trends Cell Biol. 15: 128-137. http://dx.doi.org/10.1016/j.tcb.2005.01.008
97. Nguyen, L.V., R. Vanner, P. Dirks, and C.J. Eaves. 2012. Cancer stem cells: an evolving concept. Nat. Rev. Cancer. 12:133-143.
98. Notta, F., C.G. Mullighan, J.C. Wang, A. Poeppl, S. Doulatov, L.A. Phillips, J. Ma, M.D. Minden, J.R. Downing, and J.E. Dick. 2011. Evolution of human BCR-ABL1 lymphoblastic leukaemia-initiating cells. Nature. 469: 362-367. http://dx.doi.org/10.1038/nature09733
99. O'Brien, C.A., A. Pollett, S. Gallinger, and J.E. Dick. 2007. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature. 445: 106-110. http://dx.doi.org/10.1038/nature05372
100. Odoux, C., H. Fohrer, T. Hoppo, L. Guzik, D.B. Stolz, D.W. Lewis, S.M. Gollin, T.C. Gamblin, D.A. Geller, and E. Lagasse. 2008. A stochastic model for cancer stem cell origin in metastatic colon cancer. Cancer Res. 68: 6932-6941. http://dx.doi.org/10.1158/0008-5472.CAN-07-5779
101. Oravecz-Wilson, K.I., S.T. Philips, O.H. Yilmaz, H.M. Ames, L. Li, B.D. Crawford, A.M. Gauvin, P.C. Lucas, K. Sitwala, J.R. Downing, et al. 2009. Persistence of leukemia-initiating cells in a conditional knockin model of an imatinib-responsive myeloproliferative disorder. Cancer Cell. 16: 137-148. http://dx.doi.org/10.1016/j.ccr.2009.06.007
102. Orian-Rousseau, V. 2010. CD44, a therapeutic target for metastasising tumours. Eur. J. Cancer. 46: 1271-1277. http://dx.doi.org/10.1016/j.ejca.2010.02.024
103. Oskarsson, T., S. Acharyya, X.H. Zhang, S. Vanharanta, S.F. Tavazoie, P.G. Morris, R.J. Downey, K. Manova-Todorova, E. Brogi, and J. Massagué. 2011. Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs. Nat. Med. 17: 867-874. http://dx.doi.org/10.1038/nm.2379
104. Pang, R., W.L. Law, A.C. Chu, J.T. Poon, C.S. Lam, A.K. Chow, L. Ng, L.W. Cheung, X.R. Lan, H.Y. Lan, et al. 2010. A subpopulation of CD26+ cancer stem cells with metastatic capacity in human colorectal cancer. Cell Stem Cell. 6: 603-615. http://dx.doi.org/10.1016/j.stem.2010.04.001
105. Pantel, K., C. Alix-Panabières, and S. Riethdorf. 2009. Cancer micrometastases. Nat Rev Clin Oncol. 6: 339-351. http://dx.doi.org/10.1038/nrclinonc.2009.44
106. Park, D., D.B. Sykes, and D.T. Scadden. 2012. The hematopoietic stem cell niche. Front. Biosci. 17: 30-39. http://dx.doi.org/10.2741/3913
107. Pearce, D.J., D. Taussig, C. Simpson, K. Allen, A.Z. Rohatiner, T.A. Lister, and D. Bonnet. 2005. Characterization of cells with a high aldehyde dehydrogenase activity from cord blood and acute myeloid leukemia samples. Stem Cells. 23: 752-760. http://dx.doi.org/10.1634/stemcells.2004-0292
108. Pece, S., D. Tosoni, S. Confalonieri, G. Mazzarol, M. Vecchi, S. Ronzoni, L. Bernard, G. Viale, P.G. Pelicci, and P.P. Di Fiore. 2010. Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content. Cell. 140: 62-73. http://dx.doi.org/10.1016/j.cell.2009.12.007
109. Perou, C.M., T. Sørlie, M.B. Eisen, M. van de Rijn, S.S. Jeffrey, C.A. Rees, J.R. Pollack, D.T. Ross, H. Johnsen, L.A. Akslen, et al. 2000. Molecular portraits of human breast tumours. Nature. 406: 747-752. http://dx.doi.org/10.1038/35021093
110. Perrotti, D., C. Jamieson, J. Goldman, and T. Skorski. 2010. Chronic myeloid leukemia: mechanisms of blastic transformation. J. Clin. Invest. 120: 2254-2264. http://dx.doi.org/10.1172/JCI41246
111. Piccirillo, S.G., B.A. Reynolds, N. Zanetti, G. Lamorte, E. Binda, G. Broggi, H. Brem, A. Olivi, F. Dimeco, and A.L. Vescovi. 2006. Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. Nature. 444: 761-765. http://dx.doi.org/10.1038/nature05349
112. Prince, M.E., R. Sivanandan, A. Kaczorowski, G.T. Wolf, M.J. Kaplan, P. Dalerba, I.L. Weissman, M.F. Clarke, and L.E. Ailles. 2007. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc. Natl. Acad. Sci. USA. 104: 973-978. http://dx.doi.org/10.1073/pnas.0610117104
113. Psaila, B., R.N. Kaplan, E.R. Port, and D. Lyden. 2006-2007. Priming the 'soil' for breast cancer metastasis: the pre-metastatic niche. Breast Dis. 26:65-74.
114. Quintana, E., M. Shackleton, M.S. Sabel, D.R. Fullen, T.M. Johnson, and S.J. Morrison. 2008. Efficient tumour formation by single human melanoma cells. Nature. 456: 593-598. http://dx.doi.org/10.1038/nature07567
115. Quintana, E., M. Shackleton, H.R. Foster, D.R. Fullen, M.S. Sabel, T.M. Johnson, and S.J. Morrison. 2010. Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized. Cancer Cell. 18: 510-523. http://dx.doi.org/10.1016/j.ccr.2010.10.012
116. Ran, D., M. Schubert, I. Taubert, V. Eckstein, F. Bellos, A. Jauch, H. Chen, T. Bruckner, R. Saffrich, P. Wuchter, and A.D. Ho. 2012. Heterogeneity of leukemia stem cell candidates at diagnosis of acute myeloid leukemia and their clinical significance. Exp. Hematol. 40:155-165.e1. http://dx.doi.org/10.1016/j.exphem.2011.10.005
117. Reya, T., S.J. Morrison, M.F. Clarke, and I.L. Weissman. 2001. Stem cells, cancer, and cancer stem cells. Nature. 414: 105-111. http://dx.doi.org/10.1038/35102167
118. Rhim, A.D., E.T. Mirek, N.M. Aiello, A. Maitra, J.M. Bailey, F. McAllister, M. Reichert, G.L. Beatty, A.K. Rustgi, R.H. Vonderheide, et al. 2012. EMT and dissemination precede pancreatic tumor formation. Cell. 148: 349-361. http://dx.doi.org/10.1016/j.cell.2011.11.025
119. Riechelmann, H., A. Sauter, W. Golze, G. Hanft, C. Schroen, K. Hoermann, T. Erhardt, and S. Gronau. 2008. Phase I trial with the CD44v6-targeting immunoconjugate bivatuzumab mertansine in head and neck squamous cell carcinoma. Oral Oncol. 44: 823-829. http://dx.doi.org/10.1016/j.oraloncology.2007.10.009
120. Romagosa, C., S. Simonetti, L. López-Vicente, A. Mazo, M.E. Lleonart, J. Castellvi, and S. Ramon y Cajal. 2011. p16(Ink4a) overexpression in cancer: a tumor suppressor gene associated with senescence and high-grade tumors. Oncogene. 30: 2087-2097. http://dx.doi.org/10.1038/onc.2010.614
121. Ross, D.M., T.P. Hughes, and J.V. Melo. 2011. Do we have to kill the last CML cell? Leukemia. 25:193-200. http://dx.doi.org/10.1038/leu.2010.197
122. Saito, Y., N. Uchida, S. Tanaka, N. Suzuki, M. Tomizawa-Murasawa, A. Sone, Y. Najima, S. Takagi, Y. Aoki, A. Wake, et al. 2010. Induction of cell cycle entry eliminates human leukemia stem cells in a mouse model of AML. Nat. Biotechnol. 28:275-280.
123. Scaffidi, P., and T. Misteli. 2011. In vitro generation of human cells with cancer stem cell properties. Nat. Cell Biol. 13: 1051-1061. http://dx.doi.org/10.1038/ncb2308
124. Schatton, T., G.F. Murphy, N.Y. Frank, K. Yamaura, A.M. Waaga-Gasser, M. Gasser, Q. Zhan, S. Jordan, L.M. Duncan, C. Weishaupt, et al. 2008. Identification of cells initiating human melanomas. Nature. 451: 345-349. http://dx.doi.org/10.1038/nature06489
125. Schubert, J., and T. Brabletz. 2011. p53 Spreads out further: suppression of EMT and stemness by activating miR-200c expression. Cell Res. 21: 705-707. http://dx.doi.org/10.1038/cr.2011.62
126. Seita, J., and I.L. Weissman. 2010. Hematopoietic stem cell: self-renewal versus differentiation. Wiley Interdiscip. Rev. Syst. Biol. Med. 2: 640-653. http://dx.doi.org/10.1002/wsbm.86
127. Sell, S., and G.B. Pierce. 1994. Maturation arrest of stem cell differentiation is a common pathway for the cellular origin of teratocarcinomas and epithelial cancers. Lab. Invest. 70:6-22.
128. Sharma, S.V., D.Y. Lee, B. Li, M.P. Quinlan, F. Takahashi, S. Maheswaran, U. McDermott, N. Azizian, L. Zou, M.A. Fischbach, et al. 2010. A chromatinmediated reversible drug-tolerant state in cancer cell subpopulations. Cell. 141: 69-80. http://dx.doi.org/10.1016/j.cell.2010.02.027
129. Shen, J., and Z. Zhu. 2008. Catumaxomab, a rat/murine hybrid trifunctional bispecific monoclonal antibody for the treatment of cancer. Curr. Opin. Mol. Ther. 10:273-284.
130. Shiao, S.L., A.P. Ganesan, H.S. Rugo, and L.M. Coussens. 2011. Immune microenvironments in solid tumors: new targets for therapy. Genes Dev. 25: 2559-2572. http://dx.doi.org/10.1101/gad.169029.111
131. Shimono, Y., M. Zabala, R.W. Cho, N. Lobo, P. Dalerba, D. Qian, M. Diehn, H. Liu, S.P. Panula, E. Chiao, et al. 2009. Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell. 138: 592-603. http://dx.doi.org/10.1016/j.cell.2009.07.011
132. Shiozawa, Y., E.A. Pedersen, A.M. Havens, Y. Jung, A. Mishra, J. Joseph, J.K. Kim, L.R. Patel, C. Ying, A.M. Ziegler, et al. 2011. Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow. J. Clin. Invest. 121: 1298-1312. http://dx.doi.org/10.1172/JCI43414
133. Singh, S.K., C. Hawkins, I.D. Clarke, J.A. Squire, J. Bayani, T. Hide, R.M. Henkelman, M.D. Cusimano, and P.B. Dirks. 2004. Identification of human brain tumour initiating cells. Nature. 432: 396-401. http://dx.doi.org/10.1038/nature03128
134. Sládek, N.E., R. Kollander, L. Sreerama, and D.T. Kiang. 2002. Cellular levels of aldehyde dehydrogenases (ALDH1A1 and ALDH3A1) as predictors of therapeutic responses to cyclophosphamide-based chemotherapy of breast cancer: a retrospective study. Rational individualization of oxazaphosphorine-based cancer chemotherapeutic regimens. Cancer Chemother. Pharmacol. 49: 309-321. http://dx.doi.org/10.1007/s00280-001-0412-4
135. Takahashi, K., and S. Yamanaka. 2006. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 126: 663-676. http://dx.doi.org/10.1016/j.cell.2006.07.024
136. Takahashi, K., K. Tanabe, M. Ohnuki, M. Narita, T. Ichisaka, K. Tomoda, and S. Yamanaka. 2007. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 131: 861-872. http://dx.doi.org/10.1016/j.cell.2007.11.019
137. Taussig, D.C., D.J. Pearce, C. Simpson, A.Z. Rohatiner, T.A. Lister, G. Kelly, J.L. Luongo, G.A. Danet-Desnoyers, and D. Bonnet. 2005. Hematopoietic stem cells express multiple myeloid markers: implications for the origin and targeted therapy of acute myeloid leukemia. Blood. 106: 4086-4092. http://dx.doi.org/10.1182/blood-2005-03-1072
138. Taussig, D.C., F. Miraki-Moud, F. Anjos-Afonso, D.J. Pearce, K. Allen, C. Ridler, D. Lillington, H. Oakervee, J. Cavenagh, S.G. Agrawal, et al. 2008. Anti-CD38 antibody-mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells. Blood. 112: 568-575. http://dx.doi.org/10.1182/blood-2007-10-118331
139. Tehranchi, R., P.S. Woll, K. Anderson, N. Buza-Vidas, T. Mizukami, A.J. Mead, I. Astrand-Grundström, B. Strömbeck, A. Horvat, H. Ferry, et al. 2010. Persistent malignant stem cells in del(5q) myelodysplasia in remission. N. Engl. J. Med. 363: 1025-1037. http://dx.doi.org/10.1056/NEJMoa0912228
140. Theodoropoulos, P.A., H. Polioudaki, S. Agelaki, G. Kallergi, Z. Saridaki, D. Mavroudis, and V. Georgoulias. 2010. Circulating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancer. Cancer Lett. 288: 99-106. http://dx.doi.org/10.1016/j.canlet.2009.06.027
141. Thiery, J.P., H. Acloque, R.Y. Huang, and M.A. Nieto. 2009. Epithelial-mesenchymal transitions in development and disease. Cell. 139: 871-890. http://dx.doi.org/10.1016/j.cell.2009.11.007
142. Tian, H., B. Biehs, S. Warming, K.G. Leong, L. Rangell, O.D. Klein, and F.J. de Sauvage. 2011. A reserve stem cell population in small intestine renders Lgr5-positive cells dispensable. Nature. 478: 255-259. http://dx.doi.org/10.1038/nature10408
143. Trumpp, A., and O.D. Wiestler. 2008. Mechanisms of Disease: cancer stem cells-targeting the evil twin. Nat. Clin. Pract. Oncol. 5:337-347.
144. Turhan, A.G., F.M. Lemoine, C. Debert, M.L. Bonnet, C. Baillou, F. Picard, E.A. Macintyre, and B. Varet. 1995. Highly purified primitive hematopoietic stem cells are PML-RARA negative and generate nonclonal progenitors in acute promyelocytic leukemia. Blood. 85:2154-2161.
145. Utikal, J., J.M. Polo, M. Stadtfeld, N. Maherali, W. Kulalert, R.M. Walsh, A. Khalil, J.G. Rheinwald, and K. Hochedlinger. 2009. Immortalization eliminates a roadblock during cellular reprogramming into iPS cells. Nature. 460: 1145-1148. http://dx.doi.org/10.1038/nature08285
146. Vaillant, F., M.L. Asselin-Labat, M. Shackleton, N.C. Forrest, G.J. Lindeman, and J.E. Visvader. 2008. The mammary progenitor marker CD61/beta3 integrin identifies cancer stem cells in mouse models of mammary tumorigenesis. Cancer Res. 68: 7711-7717. http://dx.doi.org/10.1158/0008-5472.CAN-08-1949
147. van der Flier, L.G., and H. Clevers. 2009. Stem cells, self-renewal, and differentiation in the intestinal epithelium. Annu. Rev. Physiol. 71: 241-260. http://dx.doi.org/10.1146/annurev.physiol.010908.163145
148. Vermeulen, L., F. De Sousa E Melo, M. van der Heijden, K. Cameron, J.H. de Jong, T. Borovski, J.B. Tuynman, M. Todaro, C. Merz, H. Rodermond, et al. 2010. Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat. Cell Biol. 12: 468-476. http://dx.doi.org/10.1038/ncb2048
149. Visvader, J.E. 2011. Cells of origin in cancer. Nature. 469: 314-322. http://dx.doi.org/10.1038/nature09781
150. Weinstein, I.B. 2002. Cancer. Addiction to oncogenes-the Achilles heal of cancer. Science. 297: 63-64. http://dx.doi.org/10.1126/science.1073096
151. Wellner, U., J. Schubert, U.C. Burk, O. Schmalhofer, F. Zhu, A. Sonntag, B. Waldvogel, C. Vannier, D. Darling, A. zur Hausen, et al. 2009. The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat. Cell Biol. 11: 1487-1495. http://dx.doi.org/10.1038/ncb1998
152. Wilson, A., E. Laurenti, G. Oser, R.C. van der Wath, W. Blanco-Bose, M. Jaworski, S. Offner, C.F. Dunant, L. Eshkind, E. Bockamp, et al. 2008. Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair. Cell. 135: 1118-1129. http://dx.doi.org/10.1016/j.cell.2008.10.048
153. Wulf, G.G., R.Y. Wang, I. Kuehnle, D. Weidner, F. Marini, M.K. Brenner, M. Andreeff, and M.A. Goodell. 2001. A leukemic stem cell with intrinsic drug efflux capacity in acute myeloid leukemia. Blood. 98: 1166-1173. http://dx.doi.org/10.1182/blood.V98.4.1166
154. Yachida, S., S. Jones, I. Bozic, T. Antal, R. Leary, B. Fu, M. Kamiyama, R.H. Hruban, J.R. Eshleman, M.A. Nowak, et al. 2010. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature. 467: 1114-1117. http://dx.doi.org/10.1038/nature09515
155. Yang, Z.F., D.W. Ho, M.N. Ng, C.K. Lau, W.C. Yu, P. Ngai, P.W. Chu, C.T. Lam, R.T. Poon, and S.T. Fan. 2008. Significance of CD90+ cancer stem cells in human liver cancer. Cancer Cell. 13: 153-166. http://dx.doi.org/10.1016/j.ccr.2008.01.013
156. Yilmaz, O.H., R. Valdez, B.K. Theisen, W. Guo, D.O. Ferguson, H. Wu, and S.J. Morrison. 2006. Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells. Nature. 441: 475-482. http://dx.doi.org/10.1038/nature04703
157. Yu, J., M.A. Vodyanik, K. Smuga-Otto, J. Antosiewicz-Bourget, J.L. Frane, S. Tian, J. Nie, G.A. Jonsdottir, V. Ruotti, R. Stewart, et al. 2007. Induced pluripotent stem cell lines derived from human somatic cells. Science. 318: 1917-1920. http://dx.doi.org/10.1126/science.1151526
158. Zhang, M., F. Behbod, R.L. Atkinson, M.D. Landis, F. Kittrell, D. Edwards, D. Medina, A. Tsimelzon, S. Hilsenbeck, J.E. Green, et al. 2008. Identification of tumor-initiating cells in a p53-null mouse model of breast cancer. Cancer Res. 68: 4674-4682. http://dx.doi.org/10.1158/0008-5472.CAN-07-6353
159. Zhang, W.C., N. Shyh-Chang, H. Yang, A. Rai, S. Umashankar, S. Ma, B.S. Soh, L.L. Sun, B.C. Tai, M.E. Nga, et al. 2012. Glycine decarboxylase activity drives non-small cell lung cancer tumor-initiating cells and tumorigenesis. Cell. 148: 259-272. (published erratum appears in Cell. 2012. 148:1066) http://dx.doi.org/10.1016/j.cell.2011.11.050
160. Zöller, M. 2011. CD44: can a cancer-initiating cell profit from an abundantly expressed molecule? Nat. Rev. Cancer. 11:254-267. http://dx.doi.org/10.1038/nrc3023